Determinants of tuberculosis treatment failure in public health facilities of Jigjiga Town, Somali Regional State, Ethiopia: A multi-center case-control study

IF 1.7 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Clinical Epidemiology and Global Health Pub Date : 2025-03-01 Epub Date: 2025-01-16 DOI:10.1016/j.cegh.2025.101936
Nasir Tayib Nur , Yadeta Dessie , Samuel Demissie Darcho , Samrawit Berihun , Behailu Hawulte Ayele
{"title":"Determinants of tuberculosis treatment failure in public health facilities of Jigjiga Town, Somali Regional State, Ethiopia: A multi-center case-control study","authors":"Nasir Tayib Nur ,&nbsp;Yadeta Dessie ,&nbsp;Samuel Demissie Darcho ,&nbsp;Samrawit Berihun ,&nbsp;Behailu Hawulte Ayele","doi":"10.1016/j.cegh.2025.101936","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Early identification of determinants of tuberculosis treatment failure is crucial in resource-limited developing countries. Tuberculosis treatment failure is one of the challenges to controlling tuberculosis. However, evidence on the factors contributing to tuberculosis treatment failure is limited. Therefore, this study aims to determine the factors contributing to tuberculosis treatment failure.</div></div><div><h3>Methods</h3><div>A retrospective, unmatched case-control study design was conducted by recruiting 264 (53 cases and 211 controls) at public health facilities. Cases were patients with pulmonary tuberculosis with a tuberculosis treatment outcome registered as treatment failure. Controls were patients with pulmonary tuberculosis with tuberculosis treatment outcomes registered as cured and treatment completed during anti-tuberculosis treatment.</div></div><div><h3>Result</h3><div>264 records (53 cases and 211 controls) were included from tuberculosis registers. In the current study, determinants of tuberculosis treatment failure were being male (AOR = 4.06, 95 % CI: 1.65, 9.75), age 30–40 years (AOR = 0.24, 95 % CI: 0.10, 0.54), receiving directly observed therapy treatment (AOR = 3.94, 95 % CI: 1.63, 9.51), adherence to tuberculosis medication (AOR = 7.56, 95 % CI: 2.70, 20.78), being treated at a hospital (AOR = 11.89, 95 % CI: 3.80, 33.79), and being HIV positive (AOR = 4.783, 95 % CI: 1.46, 15.65). (Table 4)</div></div><div><h3>Conclusions</h3><div>This study found that the rate of tuberculosis treatment failure among adult patients with pulmonary tuberculosis was relatively lower in Eastern Ethiopia. Targeted interventions should be implemented to address the identified risk factors, particularly among high-risk groups, to improve tuberculosis treatment outcomes throughout the treatment process.</div></div>","PeriodicalId":46404,"journal":{"name":"Clinical Epidemiology and Global Health","volume":"32 ","pages":"Article 101936"},"PeriodicalIF":1.7000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Epidemiology and Global Health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213398425000259","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/16 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Early identification of determinants of tuberculosis treatment failure is crucial in resource-limited developing countries. Tuberculosis treatment failure is one of the challenges to controlling tuberculosis. However, evidence on the factors contributing to tuberculosis treatment failure is limited. Therefore, this study aims to determine the factors contributing to tuberculosis treatment failure.

Methods

A retrospective, unmatched case-control study design was conducted by recruiting 264 (53 cases and 211 controls) at public health facilities. Cases were patients with pulmonary tuberculosis with a tuberculosis treatment outcome registered as treatment failure. Controls were patients with pulmonary tuberculosis with tuberculosis treatment outcomes registered as cured and treatment completed during anti-tuberculosis treatment.

Result

264 records (53 cases and 211 controls) were included from tuberculosis registers. In the current study, determinants of tuberculosis treatment failure were being male (AOR = 4.06, 95 % CI: 1.65, 9.75), age 30–40 years (AOR = 0.24, 95 % CI: 0.10, 0.54), receiving directly observed therapy treatment (AOR = 3.94, 95 % CI: 1.63, 9.51), adherence to tuberculosis medication (AOR = 7.56, 95 % CI: 2.70, 20.78), being treated at a hospital (AOR = 11.89, 95 % CI: 3.80, 33.79), and being HIV positive (AOR = 4.783, 95 % CI: 1.46, 15.65). (Table 4)

Conclusions

This study found that the rate of tuberculosis treatment failure among adult patients with pulmonary tuberculosis was relatively lower in Eastern Ethiopia. Targeted interventions should be implemented to address the identified risk factors, particularly among high-risk groups, to improve tuberculosis treatment outcomes throughout the treatment process.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
埃塞俄比亚索马里地区国家吉吉加镇公共卫生设施中结核病治疗失败的决定因素:一项多中心病例对照研究
背景:在资源有限的发展中国家,明确结核病治疗失败的决定因素至关重要。结核病治疗失败是结核病控制面临的挑战之一。然而,有关导致结核病治疗失败的因素的证据有限。因此,本研究旨在确定导致结核病治疗失败的因素。方法采用回顾性、非配对病例对照研究设计,在公共卫生机构招募264人(53例和211例对照)。病例为肺结核患者,结核病治疗结果登记为治疗失败。对照组为肺结核患者,结核病治疗结果登记为治愈,并在抗结核治疗期间完成治疗。结果共收集结核病历264份(病例53份,对照211份)。在最近的研究中,肺结核治疗失败的决定因素是男性(AOR = 4.06, 95% CI: 1.65, 9.75), 30 - 40岁(AOR = 0.24, 95% CI: 0.10, 0.54),接受直接观察治疗治疗(AOR = 3.94, 95% CI: 1.63, 9.51),坚持结核病药物(AOR = 7.56, 95% CI: 2.70, 20.78),在医院接受治疗(AOR = 11.89, 95% CI: 3.80, 33.79),和HIV阳性(AOR = 4.783, 95% CI: 1.46, 15.65)。(表4)结论本研究发现,埃塞俄比亚东部成年肺结核患者的结核病治疗失败率相对较低。应实施有针对性的干预措施,以解决已确定的风险因素,特别是在高危人群中,以在整个治疗过程中改善结核病的治疗结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Epidemiology and Global Health
Clinical Epidemiology and Global Health PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
4.60
自引率
7.70%
发文量
218
审稿时长
66 days
期刊介绍: Clinical Epidemiology and Global Health (CEGH) is a multidisciplinary journal and it is published four times (March, June, September, December) a year. The mandate of CEGH is to promote articles on clinical epidemiology with focus on developing countries in the context of global health. We also accept articles from other countries. It publishes original research work across all disciplines of medicine and allied sciences, related to clinical epidemiology and global health. The journal publishes Original articles, Review articles, Evidence Summaries, Letters to the Editor. All articles published in CEGH are peer-reviewed and published online for immediate access and citation.
期刊最新文献
Early postnatal glucose patterns and risk factors for hypoglycemia in healthy at-risk neonates: A prospective observational study Perspectives of cardiac care providers on the continuum of care among women with cardiovascular disease in a tertiary care hospital of South India Reasons for medication non-adherence among diabetes mellitus patients in Kelantan: A cross-sectional study LDL-cholesterol goal achievement and guideline adherence among middle-to older-age Irish adults in a primary care setting Survival analysis of syphilis infection in pregnant women of Papuan and non-Papuan ethnicities in Jayapura City and Regency, Papua, Indonesia
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1